Frontier Medicines Stock
HealthTechLooking to sell Frontier Medicines stock or options?
Frontier Medicines has developed a chemoproteomics platform aimed at speeding up the creation of new drugs. This platform combines computational techniques with machine learning to identify and target novel binding sites on proteins, making these sites accessible for small-molecule drug discovery and development. This innovation allows healthcare professionals to offer medications that can alter the trajectory of debilitating diseases, ultimately benefiting patients.
Driehaus Capital Management, ArrowMark Partners, Deep Track Capital, Sphera Funds Management, RA Capital Management, Galapagos (Biotechnology), Woodline Partners, Droia Ventures, Deerfield Management, Berkeley Catalyst Fund, Johnson & Johnson Innovation - JLABS, DCVC Bio, MPM BioImpact.